Hm Payson & CO Alector, Inc. Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$13.02 - $20.78 $2,395 - $3,823	-184 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$19.35 - $25.54 $3,560 - $4,699	184 New	184 $4,000
Q2 2021 Aug 17, 2021	SELL	$15.5 - $22.48 $6,138 - $8,902	-396 Closed	0 $0
Q4 2020 Mar 10, 2021	SELL	$9.4 - $16.7 $4,935 - $8,767	-525 Reduced 57.0%	396 $6,000
Q3 2020 Dec 21, 2020	BUY	$10.54 - $24.96 $9,707 - $22,988	921 New	921 $10,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $153M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.